During the past decade, Lovelace Medical Center-Downtown conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 36 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 17 clinical trials were completed. i.e. 850% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lovelace Medical Center-Downtown" #1 sponsor was "SWOG Cancer Research Network" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "National Cancer Institute (NCI)" with 7 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lovelace Medical Center-Downtown" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "American College of Surgeons" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Lovelace Medical Center-Downtown" are "Breast Cancer" (17 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Prostate Cancer" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials) and "Metastatic Cancer" (4 trials). Many other conditions were trialed in "Lovelace Medical Center-Downtown" in a lesser frequency.

Most popular intervention types in "Lovelace Medical Center-Downtown" are "Drug" (40 trials), "Other" (32 trials), "Radiation" (10 trials), "Biological" (9 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "placebo" (11 trials), "Nivolumab" (5 trials), "Placebo" (4 trials) and "Biospecimen Collection" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lovelace Medical Center-Downtown" are 34 trials for "All" genders, 14 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Lovelace Medical Center-Downtown". undefined are not yet recruiting, 5 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Lovelace Medical Center-Downtown, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lovelace Medical Center-Downtown, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Lovelace Medical Center-Downtown has several departments that took part in Clinical trials: "New Mexico Heart Institute" - 48 trials, "Lovelace Radiation Oncology" - 15 trials